Is Veeva Systems Stock a Buy Now?
Information technology businesses can be especially good investments when they market their products to the healthcare sector. Between their ability to scale quickly and offer tools to address the legal or regulatory walls inherent to healthcare, such companies have a huge profit potential that can often stand the test of time.
That's definitely true of Veeva Systems (NYSE: VEEV) and its end-to-end data management solutions for laboratories, hospitals, and pharmaceutical manufacturing. But there are a few things that investors should know about before taking the plunge and buying the stock, so let's go over the case for Veeva.
Veeva's software platform enables life sciences companies to keep track of their data across a significant portion of the value chain, including clinical trial data and clinical operations management, manufacturing quality control, and information related to regulatory submissions. That means it's upstream in the value chain of most biopharma and medtech businesses, which in turn means that it stands to benefit from the expansion of those underlying industries.
Source Fool.com
